Hearing Aid Cost Statistics (2026)

Buyers paid an average of $2,694 a pair for hearing aids in 2025, and a median of $1,999, according to HearingTracker's 2025 survey of 879 US pair purchases. HearingTracker is a consumer review site and the survey is of its own readers, so it is industry data. No federal agency publishes a current hearing aid price.

Prices in that survey ran from $20 to more than $8,500 a pair. The average was $4,672 in 2018, so it fell 42% in seven years.

Most of that fall came from buyers moving to cheaper channels. Clinic prices paid without insurance barely changed.

At a traditional clinic, buyers paying without insurance averaged $4,727 a pair, with a median of $5,000. With insurance the clinic average was $2,567. Costco averaged $1,674 and over-the-counter pairs $502.

The clinic price paid privately was $4,672 in 2018 and $4,727 in late 2025, so it barely moved. The overall average dropped because a larger share of buyers used insurance, Costco or OTC aids.

By place of purchase, hospital and university clinics averaged $3,941 a pair, local clinics $3,601, national chains $3,403, ENT offices $2,701, online sellers with a remote fitting $2,643 and online sellers with no fitting $922.

Top-end hearing aids averaged $5,225 a pair for buyers paying privately, mid-range $4,018 and low-end $2,150. With insurance the same tiers averaged $3,531, $1,970 and $1,481.

Top-end was still the most common tier bought, at 50.1% of purchases, down from 54% in 2018.

Who fits the aid also shows up in the price. Buyers fitted by an audiologist paid an average of $4,110 privately and $2,351 with insurance. Those fitted by a hearing instrument specialist paid $2,369 and $2,017.

The National Academies put the average retail price of a pair at $4,700 in 2013, a bundled price that included the audiologist's services.

The President's Council of Advisors on Science and Technology (PCAST) cited a 2014 survey putting the average price of one hearing aid at $2,363, with premium models at $2,898. It also noted that many, if not most, people need two, which doubles the cost.

In its impact analysis for the OTC rule, the FDA used $1,657 as the 2014 cost of an economy-level aid bundled with professional services ($1,849 in 2020 dollars), and $399 as the cheapest aid it could find online.

A 2010 study cited by PCAST found a hearing aid's components then cost less than $100. A Consumer Reports analysis found an average markup of 120% over the wholesale device price, so the device itself was less than half of what a buyer paid.

The rest is the service bundle: testing, fitting, adjustment visits and follow-up, sold as one price. More than 80% of hearing-care professionals bundled this way in 2014.

PCAST reported that the VA, a large buyer, bought hearing aids from the major manufacturers at about $400 per unit, and that Costco sold its house brand, fitting included, for about a third of the typical retail price.

Congress created the over-the-counter category in the FDA Reauthorization Act of 2017, signed on August 18, 2017. The FDA's final rule took effect on October 17, 2022, after more than 1,000 public comments.

OTC hearing aids are for adults 18 and older with perceived mild to moderate hearing loss, and they can be bought without an exam or a prescription (FDA). Aids for children and for severe loss stay prescription-only.

The rule caps output at 111 decibels of sound pressure level, or 117 dB with input-controlled compression switched on. Existing devices had until April 14, 2023 to comply.

In HearingTracker's 2025 survey, OTC pairs averaged $502 and had a median of $200. Prescription pairs bought privately, Costco included, averaged $3,432.

The OTC figure rests on 75 purchases, so it is a rough guide. OTC aids sold for as little as $20 a pair.

Before the rule, the FDA described the price range as running from under $100 for some personal sound amplification products to several hundred dollars online and a few thousand at a clinic. PCAST cited Consumer Reports prices of $25 to $500 for behind-the-ear amplifiers, which are not hearing aids.

The FDA estimated savings "on the order of $1,438 per unit" for a buyer who moves from an economy clinic aid to a low-cost OTC aid, about $127 million a year in total (FDA, 2020 dollars).

Its model assumed a shift of 4.4 percentage points toward low-cost aids, or about 88,210 hearing aids a year. In 2008, the last year it could find data for, about 4.7% of hearing aid sales were low-cost models bought online with little or no professional service.

Annual benefits were put at a mean of $63 million, against costs of about $1 million, for net benefits of $62 million a year. The FDA based this on about 9.6 million US adults owning hearing aids in 2015, and an average device lifespan of four to six years.

About 28.8 million US adults could benefit from hearing aids (NIDCD). Among those aged 70 and older, fewer than 1 in 3 (30%) has ever used them. Among those aged 20 to 69, about 16% have.

The National Academies put the share of adults who may benefit but do not use hearing aids at 67% to 86%.

In 2019, 7.1% of adults aged 45 and over used a hearing aid: 2.3% of those aged 45 to 64 and 14.4% of those 65 and older (CDC/NCHS). Among people 65 and older, 19.2% of men and 10.6% of women used one.

About 5% of adults aged 45 to 54 have disabling hearing loss. The share is 10% at 55 to 64, 22% at 65 to 74 and 55% at 75 and older (NIDCD).

In 2019, 13.0% of adults had some difficulty hearing even when using a hearing aid, rising from 6.3% of those aged 18 to 44 to 13.6% at 45 to 64 and 26.8% at 65 and older (CDC/NCHS).

Among Medicare beneficiaries, 44% (25.9 million) report difficulty hearing and 14% use a hearing aid (KFF analysis of 2019 MCBS data).

PCAST concluded in 2015 that "cost is the largest barrier to hearing-technology adoption." It cited a survey in which 64% of people with the most serious hearing loss said they could not afford a hearing aid and more than 75% named financial factors as a barrier.

Another survey it cited found that 50% of consumers named lack of insurance coverage as a barrier. The FDA's final rule lists high cost alongside stigma and perceived value as the barriers it expected OTC aids to address.

The National Academies found that nearly all hearing aid costs are paid by the individual. Among Medicare beneficiaries, 7% (1.8 million) said there was a time in the last year when they could not get hearing care (KFF).

No. "Medicare doesn't cover hearing aids or exams for fitting hearing aids," according to Medicare.gov, and the beneficiary pays all costs. PCAST traced the exclusion to the original 1966 Medicare amendments.

Part B does cover diagnostic hearing and balance exams when a provider orders them, with the beneficiary paying 20% of the Medicare-approved amount after the deductible (Medicare.gov). The Part B deductible is $283 in 2026 and the standard premium $202.90 a month (CMS).

An audiologist can be seen once every 12 months without an order, but only for certain conditions.

In 2026, 98% of individual Medicare Advantage plans offer some hearing benefit, meaning hearing exams, hearing aids or both (KFF).

In 2021, 32% of enrollees were in plans with a maximum dollar limit, which averaged $960 and ran from $66 to $4,000. About 60% faced cost sharing for hearing aids of $5 to $3,355, and 22% paid none (KFF).

Most plans also limit how often aids are replaced: 91% of enrollees were in plans with frequency limits, most commonly one set every year.

In 2018, 8% of Medicare beneficiaries (4.6 million) used hearing services. Those who did spent an average of $914 out of pocket on hearing care, though half spent less than $60 (KFF).

The top 10% of spenders, about 400,000 people, paid $3,600 or more. KFF found no difference in hearing spending between people in traditional Medicare and Medicare Advantage.

KFF does not separate hearing aid purchases from other hearing spending, so the $914 covers all hearing care.

For veterans eligible for VA health care, hearing aids, repairs and replacement batteries come at no charge, and each battery order covers about six months (VA).

PCAST estimated in 2015 that the Veterans Health Administration accounted for about 20% of all hearing aids dispensed in the United States.

In FY2024 tinnitus was the most prevalent service-connected disability, with 3,255,323 recipients, and hearing loss was fifth, with 1,594,271 (VBA Annual Benefits Report).

For eligible children and young adults 21 and under, Medicaid pays for the diagnosis and treatment of hearing loss, including hearing aids (NIDCD). Coverage for adults varies by state.

Hearing aids "are generally not covered by health insurance companies, although some do," according to NIDCD.

In HearingTracker's survey, clinic buyers with insurance paid an average of $2,567 a pair, against $4,727 for those without.

IRS Publication 502 lists the cost of a hearing aid, and the batteries, repairs and maintenance needed to run it, as a medical expense. It is deductible only within total medical expenses above 7.5% of adjusted gross income, for those who itemize.

Health savings accounts pay for "medical care" under the same tax code definition (IRS Publication 969), which is how hearing aids qualify. The 2026 HSA contribution limits are $4,400 for self-only coverage and $8,750 for family coverage.

A $2,694 pair would use a little over 60% of a self-only HSA's 2026 contribution limit, by our arithmetic.

The Consumer Price Index has no item for hearing aids. The nearest series, medical equipment and supplies, fell 1.3% in the 12 months to September 2026 (BLS).

That index covers far more than hearing aids, so it says little about them specifically. It swung from a 10.0% fall in 2020 to a 9.2% rise in 2022.

No federal series tracks hearing aid prices, so buyer surveys such as HearingTracker's are the only current source.

The FDA's analysis used an average hearing aid lifespan of four to six years, with a mean of five, which implies about 2 million existing hearing aids being replaced each year.

At the 2025 average of $2,694 a pair, replacing a pair every five years works out to about $540 a year, by our arithmetic. At the clinic price without insurance of $4,727 it is about $945 a year.

PCAST put US hearing aid sales at about 3 million a year in 2015 and estimated that 12% to 18% of them may end up unused.

Check whether a quoted price is per aid or per pair. The federal benchmarks from 2014 are mostly per aid; HearingTracker's figures are per pair. Most people with hearing loss in both ears need two.

HearingTracker's survey is self-selected and run by a site that reviews hearing aids, so treat its averages as a guide to the market. The FDA and National Academies figures are older but come from federal reviews.

This page describes costs. It is not medical advice, and an audiologist or doctor is the right person to say whether a given hearing aid suits a given hearing loss.